{"brief_title": "Obese Patients With or Without Comorbidities (RIO-North America)", "brief_summary": "To assess the effects of weight loss and weight maintenance over a period of two years when prescribed with a hypocaloric diet in obese patients with or without comorbidities", "condition": ["Obesity", "Weight Loss"], "intervention_type": ["Drug"], "intervention_name": ["Rimonabant (SR141716)"], "criteria": "- Stable weight (variation of less than 5 kg within 3 months prior to screening visit) - BMI (Body Mass Index) of 30 or greater in patients with or without comorbidities, or BMI greater than 27 in patients with treated or untreated hypertension and/or treated or untreated dyslipidemia", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Overweight", "mesh_term": ["Body Weight", "Weight Loss", "Rimonabant"], "id": "NCT00029861"}